Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Protein Pept Lett ; 12(3): 275-80, 2005 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-15777278

RESUMEN

Peptide analogues of Tendamistat which include the most essential residues linked by novel omega-amino acids (X,Y,Z: H2N-(CH2)n-CO(2)H, where n=2-10) were designed, synthesized (Ac-Tyr(15)-X-Trp(18)-Arg(19)-Tyr(20)-Y-Thr(55)-Z-Asp(58)-Gly(59)-Tyr(60)-Ile(61)-Gly(62)-NH2), and analyzed for alpha-amylase inhibitory activity. Native dipeptide spacers sometimes were left intact at X and Z. Analogues demonstrated competitive inhibition with K(i) values ranging from 23 to 767 microM. 8-Aminooctanoic acid was the optimal linker at Y, while longer linkers were favored at the other positions.


Asunto(s)
Aminoácidos/química , Inhibidores Enzimáticos/química , Péptidos , Péptidos/química , alfa-Amilasas/antagonistas & inhibidores , Inhibidores Enzimáticos/metabolismo , Humanos , Estructura Molecular , Péptidos/síntesis química , Péptidos/metabolismo , Unión Proteica , alfa-Amilasas/metabolismo
2.
J Med Chem ; 51(21): 7010-4, 2008 Nov 13.
Artículo en Inglés | MEDLINE | ID: mdl-18921992

RESUMEN

4-((1 R,2 R)-2-Hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile [PF-0998425, (-)- 6a] is a novel, nonsteroidal androgen receptor antagonist for sebum control and treatment of androgenetic alopecia. It is potent, selective, and active in vivo. The compound is rapidly metabolized systemically, thereby reducing the risk of unwanted systemic side effects due to its primary pharmacology. (-)- 6a was tested negative in the 3T3 NRU assay, validating our rationale that reduction of conjugation might reduce potential phototoxicity.


Asunto(s)
Antagonistas de Receptores Androgénicos , Ciclohexanoles/síntesis química , Ciclohexanoles/farmacología , Nitrilos/síntesis química , Nitrilos/farmacología , Fármacos Fotosensibilizantes/síntesis química , Fármacos Fotosensibilizantes/farmacología , Piel , Cristalografía por Rayos X , Ciclohexanoles/química , Diseño de Fármacos , Ligandos , Modelos Moleculares , Estructura Molecular , Nitrilos/química , Fármacos Fotosensibilizantes/química , Receptores Androgénicos/química , Receptores Androgénicos/metabolismo , Piel/efectos de los fármacos , Piel/metabolismo , Esteroides/química , Relación Estructura-Actividad
3.
Bioorg Med Chem Lett ; 17(20): 5693-7, 2007 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-17766112

RESUMEN

A series of amino-pyridines were synthesized and evaluated for androgen antagonist activities. Among these compounds, (R)-(+)-6-[methyl-(1-phenyl-ethyl)-amino]-4-trifluoromethyl-nicotinonitrile was the most active example of this class. This compound displayed potent androgen receptor antagonist activity as well as favorable pharmacokinetic characteristics for a potential topical agent. It also demonstrated remarkable potency for stimulating hair growth in a male C3H mouse model as well as reducing sebum production in the male Syrian hamster ear model.


Asunto(s)
Aminopiridinas/química , Aminopiridinas/farmacología , Antagonistas de Receptores Androgénicos , Cabello/efectos de los fármacos , Cabello/crecimiento & desarrollo , Sebo/efectos de los fármacos , Sebo/metabolismo , Aminopiridinas/síntesis química , Animales , Relación Dosis-Respuesta a Droga , Masculino , Ratones , Ratones Endogámicos C3H , Modelos Moleculares , Estructura Molecular , Receptores Androgénicos/metabolismo , Relación Estructura-Actividad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA